(Circulation. 1997;96:4357-4363.)
© 1997 American Heart Association, Inc.
Articles |
Enhanced Myosin Light Chain Phosphorylations as a Central Mechanism for Coronary Artery Spasm in a Swine Model With Interleukin-1ß
From the Research Institute of Angiocardiology and Cardiovascular Clinic (N.K., H.S., T.K., T.Y., K.K., A.T.), Kyushu University School of Medicine, Fukuoka 812–82, Japan, and Life Science Center (M.S., I.I., T.A., Y.S.), Asahi Chemical Industry, Co. Ltd., Shizuoka 410–23, Japan.
Correspondence to Hiroaki Shimokawa, MD, PhD, The Research Institute of Angiocardiology and Cardiovascular Clinic, Kyushu University School of Medicine, 3–1-1 Maidashi, Higashi-ku, Fukuoka 812–82, Japan. E-mail shimo{at}cardiol.med.kyushu-u.ac.jp
Background Although coronary artery spasm plays an important role in a wide variety of ischemic heart diseases, the intracellular mechanism for the spasm remains to be clarified. We examined the role of myosin light chain (MLC) phosphorylations, a key mechanism for contraction of vascular smooth muscle, in our swine model with interleukin-1ß (IL-1ß).
Methods and Results IL-1ß was applied chronically to the porcine coronary arteries from the adventitia to induce an inflammatory/proliferative lesion. Two weeks after the operation, intracoronary serotonin repeatedly induced coronary hyperconstrictions at the IL-1ß-treated site both in vivo and in vitro, which were markedly inhibited by fasudil, an inhibitor of protein kinases, including protein kinase C and MLC kinase. Western blot analysis showed that during serotonin-induced contractions, MLC monophosphorylation was significantly increased and sustained in the spastic segment compared with the control segment, whereas MLC diphosphorylation was noted only in the spastic segment. A significant correlation was noted between the serotonin-induced contractions and MLC phosphorylations. Both types of MLC phosphorylation were markedly inhibited by fasudil. In addition, MLC diphosphorylation was never induced by a simple endothelium removal in the normal coronary artery, whereas enhanced MLC phosphorylations in the spastic segment were noted regardless of the presence or absence of the endothelium.
Conclusions These results indicate that enhanced MLC phosphorylations in the vascular smooth muscle play a central role in the pathogenesis of coronary spasm in our swine model.
Key Words: coronary vasospasm • myosin light chain • calcium • phosphorylation
This article has been cited by other articles:
 |
|
 |
|
  E. Ihara, P. L. Beck, M. Chappellaz, J. Wong, S. A. Medlicott, and J. A. MacDonald Mitogen-Activated Protein Kinase Pathways Contribute to Hypercontractility and Increased Ca2+ Sensitization in Murine Experimental Colitis Mol. Pharmacol., May 1, 2009; 75(5): 1031 - 1041. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-W. Wang, P.-Y. Liu, N. Oyama, Y. Rikitake, S. Kitamoto, J. Gitlin, J. K. Liao, and W. A. Boisvert Deficiency of ROCK1 in bone marrow-derived cells protects against atherosclerosis in LDLR-/- mice FASEB J, October 1, 2008; 22(10): 3561 - 3570. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Anderson, C. D. Adams, E. M. Antman, C. R. Bridges, R. M. Califf, D. E. Casey Jr, W. E. Chavey II, F. M. Fesmire, J. S. Hochman, T. N. Levin, et al. ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine J. Am. Coll. Cardiol., August 14, 2007; 50(7): e1 - e157. [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zhang, M. Adner, and L.-O. Cardell IL-1beta-Induced Transcriptional Up-Regulation of Bradykinin B1 and B2 Receptors in Murine Airways Am. J. Respir. Cell Mol. Biol., June 1, 2007; 36(6): 697 - 705. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Noma, N. Oyama, and J. K. Liao Physiological role of ROCKs in the cardiovascular system Am J Physiol Cell Physiol, March 1, 2006; 290(3): C661 - C668. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Noma, C. Goto, K. Nishioka, K. Hara, M. Kimura, T. Umemura, D. Jitsuiki, K. Nakagawa, T. Oshima, K. Chayama, et al. Smoking, Endothelial Function, and Rho-Kinase in Humans Arterioscler Thromb Vasc Biol, December 1, 2005; 25(12): 2630 - 2635. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Shimokawa and A. Takeshita Rho-Kinase Is an Important Therapeutic Target in Cardiovascular Medicine Arterioscler Thromb Vasc Biol, September 1, 2005; 25(9): 1767 - 1775. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Budzyn, P. D. Marley, and C. G. Sobey Opposing Roles of Endothelial and Smooth Muscle Phosphatidylinositol 3-Kinase in Vasoconstriction: Effects of Rho-Kinase and Hypertension J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1248 - 1253. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Hattori, H. Shimokawa, M. Higashi, J. Hiroki, Y. Mukai, H. Tsutsui, K. Kaibuchi, and A. Takeshita Long-Term Inhibition of Rho-Kinase Suppresses Left Ventricular Remodeling After Myocardial Infarction in Mice Circulation, May 11, 2004; 109(18): 2234 - 2239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kandabashi, H. Shimokawa, K. Miyata, I. Kunihiro, Y. Eto, K. Morishige, Y. Matsumoto, K. Obara, K. Nakayama, S. Takahashi, et al. Evidence for Protein Kinase C-Mediated Activation of Rho- Kinase in a Porcine Model of Coronary Artery Spasm Arterioscler Thromb Vasc Biol, December 1, 2003; 23(12): 2209 - 2214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Noma, Y. Higashi, D. Jitsuiki, K. Hara, M. Kimura, K. Nakagawa, C. Goto, T. Oshima, M. Yoshizumi, and K. Chayama Smoking Activates Rho-Kinase in Smooth Muscle Cells of Forearm Vasculature in Humans Hypertension, May 1, 2003; 41(5): 1102 - 1105. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Mohri, H. Shimokawa, Y. Hirakawa, A. Masumoto, and A. Takeshita Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm J. Am. Coll. Cardiol., January 1, 2003; 41(1): 15 - 19. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Takemoto, J. Sun, J. Hiroki, H. Shimokawa, and J. K. Liao Rho-Kinase Mediates Hypoxia-Induced Downregulation of Endothelial Nitric Oxide Synthase Circulation, July 2, 2002; 106(1): 57 - 62. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Masumoto, M. Mohri, H. Shimokawa, L. Urakami, M. Usui, and A. Takeshita Suppression of Coronary Artery Spasm by the Rho-Kinase Inhibitor Fasudil in Patients With Vasospastic Angina Circulation, April 2, 2002; 105(13): 1545 - 1547. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kandabashi, H. Shimokawa, Y. Mukai, T. Matoba, I. Kunihiro, K. Morikawa, M. Ito, S. Takahashi, K. Kaibuchi, and A. Takeshita Involvement of Rho-Kinase in Agonists-Induced Contractions of Arteriosclerotic Human Arteries Arterioscler Thromb Vasc Biol, February 1, 2002; 22(2): 243 - 248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Takemoto and J. K. Liao Pleiotropic Effects of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Arterioscler Thromb Vasc Biol, November 1, 2001; 21(11): 1712 - 1719. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Shimokawa, K. Morishige, K. Miyata, T. Kandabashi, Y. Eto, I. Ikegaki, T. Asano, K. Kaibuchi, and A. Takeshita Long-term inhibition of Rho-kinase induces a regression of arteriosclerotic coronary lesions in a porcine model in vivo Cardiovasc Res, July 1, 2001; 51(1): 169 - 177. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Morishige, H. Shimokawa, Y. Eto, T. Kandabashi, K. Miyata, Y. Matsumoto, M. Hoshijima, K. Kaibuchi, and A. Takeshita Adenovirus-Mediated Transfer of Dominant-Negative Rho-Kinase Induces a Regression of Coronary Arteriosclerosis in Pigs In Vivo Arterioscler Thromb Vasc Biol, April 1, 2001; 21(4): 548 - 554. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Okumura, T. Osanai, T. Kosugi, H. Hanada, H. Ishizaka, T. Fukushi, T. Kamada, T. Miura, T. Hatayama, T. Nakano, et al. Enhanced phospholipase C activity in the cultured skin fibroblast obtained from patients with coronary spastic angina: possible role for enhanced vasoconstrictor response J. Am. Coll. Cardiol., November 15, 2000; 36(6): 1847 - 1852. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Miyata, H. Shimokawa, T. Kandabashi, T. Higo, K. Morishige, Y. Eto, K. Egashira, K. Kaibuchi, and A. Takeshita Rho-Kinase Is Involved in Macrophage-Mediated Formation of Coronary Vascular Lesions in Pigs In Vivo Arterioscler Thromb Vasc Biol, November 1, 2000; 20(11): 2351 - 2358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Laufs and J. K. Liao Targeting Rho in Cardiovascular Disease Circ. Res., September 29, 2000; 87(7): 526 - 528. [Full Text] [PDF]
|
|
|
|
|
|
E. Braunwald, E. M. Antman, J. W. Beasley, R. M. Califf, M. D. Cheitlin, J. S. Hochman, R. H. Jones, D. Kereiakes, J. Kupersmith, T. N. Levin, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-st-segment elevation myocardial infarction: A report of the american college of cardiology/ american heart association task force on practice guidelines (committee on the management of patients with unstable angina) J. Am. Coll. Cardiol., September 1, 2000; 36(3): 970 - 1062. [Full Text] [PDF]
|
|
|
|
 |
|
 N. Matsuda, K. G. Morgan, and F. W. Sellke Effects of pinacidil on coronary Ca2+-myosin phosphorylation in cold potassium cardioplegia model Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H882 - H888. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Toshima, S.-i. Satoh, I. Ikegaki, T. Asano, and W. D. Dietrich A New Model of Cerebral Microthrombosis in Rats and the Neuroprotective Effect of a Rho-Kinase Inhibitor Editorial Comment Stroke, September 1, 2000; 31(9): 2245 - 2250. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Sawada, H. Itoh, K. Ueyama, J. Yamashita, K. Doi, T.-H. Chun, M. Inoue, K. Masatsugu, T. Saito, Y. Fukunaga, et al. Inhibition of Rho-Associated Kinase Results in Suppression of Neointimal Formation of Balloon-Injured Arteries Circulation, May 2, 2000; 101(17): 2030 - 2033. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Virmani, F. D. Kolodgie, A. P. Burke, A. Farb, and S. M. Schwartz Lessons From Sudden Coronary Death : A Comprehensive Morphological Classification Scheme for Atherosclerotic Lesions Arterioscler Thromb Vasc Biol, May 1, 2000; 20(5): 1262 - 1275. [Full Text] [PDF]
|
|
|
|
|
|
T. Kandabashi, H. Shimokawa, K. Miyata, I. Kunihiro, Y. Kawano, Y. Fukata, T. Higo, K. Egashira, S. Takahashi, K. Kaibuchi, et al. Inhibition of Myosin Phosphatase by Upregulated Rho-Kinase Plays a Key Role for Coronary Artery Spasm in a Porcine Model With Interleukin-1{beta} Circulation, March 21, 2000; 101(11): 1319 - 1323. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Miyata, H. Shimokawa, T. Yamawaki, I. Kunihiro, X. Zhou, T. Higo, E. Tanaka, N. Katsumata, K. Egashira, and A. Takeshita Endothelial Vasodilator Function Is Preserved at the Spastic/Inflammatory Coronary Lesions in Pigs Circulation, September 28, 1999; 100(13): 1432 - 1437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Shimokawa, M. Seto, N. Katsumata, M. Amano, T. Kozai, T. Yamawaki, K. Kuwata, T. Kandabashi, K. Egashira, I. Ikegaki, et al. Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm Cardiovasc Res, September 1, 1999; 43(4): 1029 - 1039. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nakano, T. Osanai, H. Tomita, M. Sekimata, Y. Homma, and K. Okumura Enhanced Activity of Variant Phospholipase C-{delta}1 Protein (R257H) Detected in Patients With Coronary Artery Spasm Circulation, April 30, 2002; 105(17): 2024 - 2029. [Abstract] [Full Text] [PDF]
|
|